Who Buys Lisinopril from India — 450 Importers Behind a $60.4M Market
India's lisinopril import market is served by 450 active buyers who collectively imported $60.4M across 3,514 shipments. MYLAN B,V, (NETHERLANDS) leads with a 32.4% market share, followed by LUPIN PHARMACEUTICAL INC and MYLAN IRELAND C/O ALLOGA RDC,. The top 5 buyers together control 62.1% of total import value, reflecting a concentrated buyer landscape.
Lisinopril buyer data — 450 importers · $60.4M market · 3,514 shipmentsTransData Nexus · Indian Customs Data
Top Lisinopril Importers — Ranked by Import Value
MYLAN B,V, (NETHERLANDS) is the leading lisinopril importer from India, holding a 32.4% share of the $60.4M market across 3,514 shipments from 450 buyers. The top 5 buyers — MYLAN B,V, (NETHERLANDS), LUPIN PHARMACEUTICAL INC (UNITED STATES), MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), XXPINXXHARXXCEUXXCALXXINC (UNITED STATES), BROWN AND BURK UK LIMITED (UNITED KINGDOM) — collectively control 62.1% of total import value.
Top Lisinopril Buyers & Importers
Ranked by import value · 450 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Lisinopril Buyers & Importers — Ranked by Import Value. 450 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Lisinopril — and from which countries?
Flow of Lisinopril exports from India: each country's share and the named importers behind the numbers
Lisinopril — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 81.0% of global Lisinopril imports — led by Netherlands (42.6%) with a total trade value of $60.4M across 3,514 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands emerges as the first largest importing country, achieving a total trade value of $25.8M through 5 shipments. This represents a market share of 42.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• MYLAN B,V, - $19.6M (75.9% of country's total business)
• MYLAN IRELAND C/O ALLOGA RDC, - $5.0M (19.4% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $5.2M, indicating premium pricing strategy compared to the market average of $17.2K.
Netherlands is a key market for Lisinopril imports, representing 42.6% of total trade value.
Primary Market
Secondary Market
2United States
United States emerges as the second largest importing country, achieving a total trade value of $15.1M through 64 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.
The importation of Lisinopril from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like MYLAN B.V. (Netherlands) and MYLAN IRELAND C/O ALLOGA RDC (Netherlands) function as intermediaries, procuring large volumes to supply regional markets. Their purchasing patterns are characterized by bulk orders and consistent procurement schedules to maintain steady supply chains.
Pharmaceutical Companies: LUPIN PHARMACEUTICAL INC (United States) and GEDEON RICHTER PLC (Hungary) are manufacturers that import Lisinopril for formulation and distribution under their brand names. Their procurement is aligned with production cycles and market demand forecasts, often involving substantial quantities to ensure production continuity.
Re-exporters: Entities such as APL SWIFT SERVICES (MALTA) LTD. (Malta) import Lisinopril with the intent to distribute it to other markets. Their purchasing behavior is influenced by global demand trends and regulatory considerations in target markets, leading to variable order sizes and frequencies.
Contract Manufacturers: Companies like BROWN AND BURK UK LIMITED (United Kingdom) may import Lisinopril to manufacture finished pharmaceutical products for other brands or markets. Their procurement is typically project-based, with volumes and schedules dictated by contractual agreements.
The demand for Lisinopril in importing countries is driven by several factors:
Disease Prevalence: Hypertension and cardiovascular diseases are leading health concerns globally. The World Health Organization (WHO) reports that cardiovascular diseases account for approximately 31% of all global deaths as of 2023.
Government Healthcare Programs: Many countries have implemented programs to manage non-communicable diseases. For instance, the United Kingdom's National Health Service (NHS) provides comprehensive coverage for hypertension management, increasing the demand for antihypertensive medications like Lisinopril.
Universal Health Coverage Expansion: Countries expanding health coverage, such as Nigeria's National Health Insurance Scheme (NHIS), are increasing access to essential medicines, thereby boosting demand.
WHO Essential Medicines List Procurement: Lisinopril's inclusion in the WHO Essential Medicines List encourages its procurement by international health organizations and governments, ensuring its availability in public health systems.
Common Questions — Lisinopril Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest lisinopril buyer importing from India?
Based on import volume and value, MYLAN B,V, (NETHERLANDS) leads with $19.6M in imports and a 32.4% market share — the highest of any single lisinopril importer. LUPIN PHARMACEUTICAL INC (UNITED STATES) and MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS) are the next largest buyers.
QHow many companies buy lisinopril from India?
There are 450 active lisinopril buyers importing from India, with a combined market of $60.4M across 3,514 shipments to 94 countries. The top 5 buyers hold 62.1% of total import value, while the remaining 445 buyers handle the other 37.9%.
QWhich countries import the most lisinopril from India?
The top importing countries for lisinopril from India are Netherlands (42.6%), United States (25.0%), Nigeria (6.1%), United Kingdom (3.8%), Georgia (3.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of lisinopril, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for lisinopril from India?
The average import transaction value for lisinopril from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Lisinopril from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like MYLAN B.V. (Netherlands) and MYLAN IRELAND C/O ALLOGA RDC (Netherlands) function as intermediaries, procuring large volumes to supply regional markets. Their purchasing patterns are characterized by bulk orders and consistent procurement schedules to maintain steady supply chains.
Pharmaceutical Companies: LUPIN PHARMACEUTICAL INC (United States) and GEDEON RICHTER PLC (Hungary) are manufacturers that import Lisinopril for formulation and distribution under their brand names. Their procurement is aligned with production cycles and market demand forecasts, often involving substantial quantities to ensure production continuity.
Re-exporters: Entities such as APL SWIFT SERVICES (MALTA) LTD. (Malta) import Lisinopril with the intent to distribute it to other markets. Their purchasing behavior is influenced by global demand trends and regulatory considerations in target markets, leading to variable order sizes and frequencies.
Contract Manufacturers: Companies like BROWN AND BURK UK LIMITED (United Kingdom) may import Lisinopril to manufacture finished pharmaceutical products for other brands or markets. Their procurement is typically project-based, with volumes and schedules dictated by contractual agreements.
The demand for Lisinopril in importing countries is driven by several factors:
Disease Prevalence: Hypertension and cardiovascular diseases are leading health concerns globally. The World Health Organization (WHO) reports that cardiovascular diseases account for approximately 31% of all global deaths as of 2023.
Government Healthcare Programs: Many countries have implemented programs to manage non-communicable diseases. For instance, the United Kingdom's National Health Service (NHS) provides comprehensive coverage for hypertension management, increasing the demand for antihypertensive medications like Lisinopril.
Universal Health Coverage Expansion: Countries expanding health coverage, such as Nigeria's National Health Insurance Scheme (NHIS), are increasing access to essential medicines, thereby boosting demand.
WHO Essential Medicines List Procurement: Lisinopril's inclusion in the WHO Essential Medicines List encourages its procurement by international health organizations and governments, ensuring its availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
25.0%
Top Importers: United States has a diverse importer base, with their top importers including:
• LUPIN PHARMACEUTICAL INC - $7.9M (52.7% of country's total business)
• XXPINXXHARXXCEUXXCALXXINC - $4.2M (27.8% of country's total business)
• XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX - $828.0K (5.5% of country's total business)
• LUPIN PHARMACEUTICALS INC - $656.7K (4.4% of country's total business)
• ACTAVIS LABORATORIES FL INC - $379.6K (2.5% of country's total business)
• Rest of United States's importers - $1.1M (7.1% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $235.7K, indicating premium pricing strategy compared to the market average of $17.2K.
United States is a key market for Lisinopril imports, representing 25.0% of total trade value.
Primary Market
Secondary Market
3Nigeria
Nigeria emerges as the third largest importing country, achieving a total trade value of $3.7M through 0 shipments. This represents a market share of 6.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $3.7M, indicating premium pricing strategy compared to the market average of $17.2K.
Nigeria is a key market for Lisinopril imports, representing 6.1% of total trade value.
Primary Market
Secondary Market
4United Kingdom
United Kingdom emerges as the fourth largest importing country, achieving a total trade value of $2.3M through 34 shipments. This represents a market share of 3.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• BROWN AND BURK UK LIMITED - $852.4K (37.2% of country's total business)
• RELONCHEM LTD - $345.8K (15.1% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $67.4K, indicating premium pricing strategy compared to the market average of $17.2K.
United Kingdom is a key market for Lisinopril imports, representing 3.8% of total trade value.
Primary Market
Secondary Market
5Georgia
Georgia emerges as the fifth largest importing country, achieving a total trade value of $2.1M through 0 shipments. This represents a market share of 3.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Georgia demonstrates strong market positioning with an average shipment value of $2.1M, indicating premium pricing strategy compared to the market average of $17.2K.
Georgia is a key market for Lisinopril imports, representing 3.5% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring supply strategies, as each has unique requirements and operational dynamics.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires an approved Abbreviated New Drug Application (ANDA) for generic drugs, along with facility registration and compliance with Current Good Manufacturing Practices (CGMP).
Estimated Timeline: ANDA approval can take 10 months or more, depending on the review process.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049071 are generally duty-free.
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Involves submission of a registration dossier, facility inspection, and product testing.
Estimated Timeline: Approximately 6 to 12 months, depending on the complexity of the application.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049071 are subject to a 5% import duty.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Requires a marketing authorization, including submission of quality, safety, and efficacy data.
Estimated Timeline: Approximately 210 days, subject to the application’s completeness.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049071 are typically exempt from import duties.
Georgia:
Regulatory Authority: State Regulation Agency for Medical Activities.
Import Registration Process: Requires submission of a registration dossier, including product samples and manufacturing documentation.
Estimated Timeline: Approximately 6 months, depending on the review process.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049071 are subject to a 0% import duty.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through competitive tendering processes, which can lead to substantial orders for Lisinopril.
With 450 buyers across 94 countries, the market for Lisinopril presents significant opportunities for suppliers, especially in regions with rising cardiovascular disease prevalence and expanding healthcare access.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$17.2K
$38.03 per unit
Understanding these segments is crucial for tailoring supply strategies, as each has unique requirements and operational dynamics.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires an approved Abbreviated New Drug Application (ANDA) for generic drugs, along with facility registration and compliance with Current Good Manufacturing Practices (CGMP).
Estimated Timeline: ANDA approval can take 10 months or more, depending on the review process.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049071 are generally duty-free.
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Involves submission of a registration dossier, facility inspection, and product testing.
Estimated Timeline: Approximately 6 to 12 months, depending on the complexity of the application.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049071 are subject to a 5% import duty.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Requires a marketing authorization, including submission of quality, safety, and efficacy data.
Estimated Timeline: Approximately 210 days, subject to the application’s completeness.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049071 are typically exempt from import duties.
Georgia:
Regulatory Authority: State Regulation Agency for Medical Activities.
Import Registration Process: Requires submission of a registration dossier, including product samples and manufacturing documentation.
Estimated Timeline: Approximately 6 months, depending on the review process.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049071 are subject to a 0% import duty.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through competitive tendering processes, which can lead to substantial orders for Lisinopril.
With 450 buyers across 94 countries, the market for Lisinopril presents significant opportunities for suppliers, especially in regions with rising cardiovascular disease prevalence and expanding healthcare access.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 450 global importers of Lisinopril identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 3,514 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 94 destination countries with market share per buyer calculated from capped values.
